Résultats de la recherche - 20 results
Surveillance des infections respiratoires aiguës: rapport épidémiologique saisons 2022-2023 et 2023-2024
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Clara Mazagatos; Sébastien Fierens; Mathil Vandromme; Claire Brugerolles; Yves Lafort; Natalia Bustos Sierra; Sven Hanoteaux; Milena Callies; Léonore Nasiadka; Rapha ...
Surveillance van acute luchtweginfecties: epidemiologisch rapport seizoenen 2022-2023 en 2023-2024
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Clara Mazagatos; Sébastien Fierens; Mathil Vandromme; Claire Brugerolles; Yves Lafort; Natalia Bustos Sierra; Sven Hanoteaux; Milena Callies; Léonore Nasiadka; Rapha ...
Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study.
Network Source: Lancet Respir Med, Volume 12, Issue 9 (2024) Keywords: Adult Aged Aged, 80 and over COVID-19 COVID-19 Vaccines Europe Female Humans Immunization Programs Male middle aged Retrospective ...
Bulletin infections respiratoires aiguës semaine 36-2025- Publié 10/09/25
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Sébastien Fierens; Claire Brugerolles; Yves Lafort; Sven Hanoteaux; Adrien Lajot; Mathil Vandromme; Yinthe Dockx; Peace Mpakanyie; Nathalie Bossuyt; Mélanie Nahimana ...
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factorsBackgroundMethodsResultsConclusionDataSheet_1.docx
Publication Type: Peer reviewed scientific article Authors: Angelina Konnova; Fien H. R. De Winter; Gupta, Akshita; Lise Verbruggen; An Hotterbeekx; Matilda Berkell; Laure-Anne Teuwen; Greetje Vanhoutte; Bart Peeters; Silke Raats; Isolde Van der Massen; S ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
Van Loon; Katelijne Dierick; André Matagne; I Desombere; Ariën, Kevin K; Arnaud Marchant; Maria Goossens Source: Vaccine, Volume 41, Issue 17 (2023) Keywords: Adult Antibodies, Viral BNT162 Vaccine ...
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: Results of the second data collection (28/09/21-23/02/22)
2 (27/09-24/10) the percentage of adults (18 years or older) with anti- SARS-CoV-2 antibodies has increased from 69.5% to 90.4%. This substantial increase is in line with the intensive vaccination campaign during ...
Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with CancerPurpose:Experimental Design:Results:Conclusions:
Publication Type: Peer reviewed scientific article Authors: Yana Debie; Jonas R.M. Van Audenaerde; Timon Vandamme; Lieselot Croes; Laure-Anne Teuwen; Lise Verbruggen; Greetje Vanhoutte; Elly Marcq; Lisa Verheggen; Debbie Le Blon; Bart Peeters; Maria Gooss ...
Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study
period, which coincided with the onset of the vaccination campaign, the seroprevalence in the population increased from 25.2% in March/April to 78.1% in July. Among the vaccinated there was an increase from ...
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study
community dwelling population aged 18 years and above had developed anti- SARS-CoV-2 antibodies. This percentage was 98.9% among fully vaccinated people (since at least 2 weeks before being tested) and 28.9% ...